In addition, HSC has a therapeutic effect on ALI through decreasing the concentration of neutrophils, lymphocytes and leukocytes, inhibiting the inflammatory cytokines production such as TNF-α, IL-1β, and IL-6, and ameliorating the lesion of lung tissues and the inflammation infiltration in the alveolar. The gene discussed is IL6; the disease is acute respiratory distress syndrome.